|
|
Volumn 288, Issue 5, 2003, Pages 81-87
|
|
The orphan drug backlash
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOTECHNOLOGY;
CELLS;
COSTS;
DISEASES;
LAWS AND LEGISLATION;
PATIENT TREATMENT;
DRUG DEVELOPMENT;
DRUG PRODUCTS;
APPARATUS, EQUIPMENT AND SUPPLIES;
ARTICLE;
BIOTECHNOLOGY;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
ECONOMICS;
EQUIPMENT DESIGN;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
RARE DISEASE;
UNITED STATES;
BIOTECHNOLOGY;
DRUG COSTS;
DRUG INDUSTRY;
EQUIPMENT AND SUPPLIES;
EQUIPMENT DESIGN;
HUMANS;
ORPHAN DRUG PRODUCTION;
RARE DISEASES;
RESEARCH SUPPORT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0037837490
PISSN: 00368733
EISSN: None
Source Type: Journal
DOI: 10.1038/scientificamerican0503-80 Document Type: Review |
|
Times cited : (34)
|
|
References (0)
|
